Law360, New York (August 19, 2008, 12:00 AM ET) -- A district judge in California has tentatively given the green light for Abbott Laboratories to seek interlocutory appeal of several contentious antitrust issues that have arisen in one of several suits the company is facing for allegedly jacking up the price of its HIV medication Norvir.
During a hearing Tuesday in federal court in Oakland, Calif., Judge Claudia Wilken indicated she was leaning in favor of granting leave for the pharmaceutical giant to apply for an interlocutory appeal to the U.S. Court of Appeals for the...
Abbott's Appeal Tentatively OK'd In Norvir Suit
To view the full article, take a free trial now.
